A Clinical Effectiveness Trial in Post-Operative Pterional Craniotomy Drain Placement (EPOP)

June 6, 2016 updated by: Wyatt Ramey, University of Arizona

A Randomized, Non-Blind, Clinical Effectiveness Trial in Post-Operative Pterional Craniotomy Drain Placement

This is a clinical trial where patients who present to the neurosurgery service in need of a procedure that requires a pterional craniotomy will be screened, and if eligible, enrolled for the randomization in the placement of a drain at the surgical site. At present, there is not a protocol for whether or not to use a drain following this procedure. There is some debate on whether it serves any real benefit for the patient or if it may actually be detrimental in cases where infection occurs. This study aims to answer this question by randomizing patients to drain placement and then comparing patient outcomes between the two groups. These include the following: infection rate, length of hospital stay, self-reported patient pain and discomfort, the amount of time before patients are able to open their eye ipsilateral to the side of operation, change in forehead circumference post-op days 1-3, and any unforeseen post-operative complications. This will be accomplished through using a patient-administered survey, recording physical measurements, and a patient chart review. Statistical analysis will then be used to identify any differences that may exist.

Study Overview

Status

Unknown

Intervention / Treatment

Study Type

Interventional

Enrollment (Anticipated)

90

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients that have been scheduled for surgery requiring the use of a pterional craniotomy approach

Exclusion Criteria:

  • Patients in need of a surgical intervention requiring a pterional craniotomy due to reasons of physical injury
  • Patients who need a pterional craniotomy with a orbitozygomatic approach
  • Patients who have noticeable physical injury to their skull
  • Patients with a prior surgical history of a craniotomy
  • Patients with a pathological condition deemed severe enough by the screening physician to possibly influence the healing process of the procedure (blood clot disorder, cirrhosis, severe nutrient depletion, congestive heart failure etc.)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control Group
Subjects who did not have a suction drain placed post-operatively following a Pterional Craniotomy.
Experimental: Treatment Group
Subjects who did have a suction drain placed post-operatively following a Pterional Craniotomy at the location of surgical incision.
The intervention of the experimental group will be a standard suction drain placed at the surgical site following a Pterional Craniotomy.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Difference in Length of Hospital Stay
Time Frame: From the date of surgery to the date of discharge from the hospital for up to 16 weeks following surgery, or until death, depending which comes first.
Compare the length of hospital between the treatment groups and determine whether a significant difference exists.
From the date of surgery to the date of discharge from the hospital for up to 16 weeks following surgery, or until death, depending which comes first.
Head Circumference Difference
Time Frame: Day 1 through Day 3 following surgery.
Compare the change in measured forehead circumference between treatment groups on post-operative days 1-3. Determine if a significant difference exists between the two.
Day 1 through Day 3 following surgery.
Pain Difference
Time Frame: At the time of discharge from the hospital but no longer than up to 16 weeks from the date of surgery.
Compare the reported pain/ discomfort between the patients who had drain placement from those who did not. This will be performed using a survey administered to patients upon removal of the drain
At the time of discharge from the hospital but no longer than up to 16 weeks from the date of surgery.
Ability to open ipsilateral eye to surgical site.
Time Frame: Day 1 through Day 3 following surgery.
Compare the number of subjects able to open and close their eye on the ipsilateral side of the surgical site between the study groups
Day 1 through Day 3 following surgery.
Complication Rate
Time Frame: From the date of surgery to the date of discharge from the hospital for up to 16 weeks following surgery, or until death, depending which comes first.
An overall assessment comparing complications between the two study groups will be performed. This will include looking things such as hospital acquired pneumonia, the development of any new neurological conditions or deficiencies, and other unforeseen complications that may arise which are not be directly related to the drain but may potentially still be influenced by it.
From the date of surgery to the date of discharge from the hospital for up to 16 weeks following surgery, or until death, depending which comes first.
Surgical site infection rate
Time Frame: From the date of surgery to the date of discharge from the hospital for up to 16 weeks following surgery, or until death, depending which comes first.
Compare infections rates between patients with drains placement versus those who did not. Determine if there is any statistically significant difference in risk exists between the two study populations.
From the date of surgery to the date of discharge from the hospital for up to 16 weeks following surgery, or until death, depending which comes first.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2016

Primary Completion (Anticipated)

June 1, 2019

Study Completion (Anticipated)

June 1, 2019

Study Registration Dates

First Submitted

May 25, 2016

First Submitted That Met QC Criteria

June 6, 2016

First Posted (Estimate)

June 7, 2016

Study Record Updates

Last Update Posted (Estimate)

June 7, 2016

Last Update Submitted That Met QC Criteria

June 6, 2016

Last Verified

May 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • SCT1121

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

IPD Plan Description

Individual participant data will not be made available. However, findings may be published in a peer-reviewed academic journal.

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe